Cited by 3,519NF-κB Signaling PathwaysSignaling Pathways in DiseaseNatural Compounds in Disease Treatment

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Nuclear factor-κB in cancer development and progression

Karin, Michael·2006·Nature

Open this paper in CoChat — free account

Abstract

Nuclear factor-kappaB (NF-kappaB) transcription factors and the signalling pathways that activate them are central coordinators of innate and adaptive immune responses. More recently, it has become clear that NF-kappaB signalling also has a critical role in cancer development and progression. NF-kappaB provides a mechanistic link between inflammation and cancer, and is a major factor controlling the ability of both pre-neoplastic and malignant cells to resist apoptosis-based tumour-surveillance mechanisms. NF-kappaB might also regulate tumour angiogenesis and invasiveness, and the signalling pathways that mediate its activation provide attractive targets for new chemopreventive and chemotherapeutic approaches.

Integrity signals

Registry

Crossref · 10.1038/nature04870

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Inflammation and cancer
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,976
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Self-citation
Cell Death
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Self-citation
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
Self-citation

Flagged first, then by citations

Show all 71 references

Sorted by citations

Items 301–400 of 1,010

Apoptosis Induction in Human Melanoma Cells by Inhibition of MEK Is Caspase-Independent and Mediated by the Bcl-2 Family Members PUMA, Bim, and Mcl-1
Wang, Y. F., Jiang, C. C., Avery‐Kiejda, K. A., Gillespie, S., Zhang, X. D., & Hersey, P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0665 · Cited by 194
Collateral damage: Insights into bacterial mechanisms that predispose host cells to cancer
Gagnaire, A., Nadel, B., Raoult, D., Neefjes, J., & Gorvel, J.-P. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.171 · Cited by 189
Loss of p53 enhances catalytic activity of IKKβ through O-linked β-N-acetyl glucosamine modification
Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813210106 · Cited by 200
Size/Charge Changeable Acidity‐Responsive Micelleplex for Photodynamic‐Improved PD‐L1 Immunotherapy with Enhanced Tumor Penetration
Dai, L., Li, K., Li, M., Zhao, X., Luo, Z. Y., Lu, L., Luo, Y., & Cai, K. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201707249 · Cited by 194
Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges
Gerhauser, C. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_360 · Cited by 194
Natural immunity to cancer in humans
Bindea, G., Mlecnik, B., Fridman, W. H., Pagès, F., & Galon, J. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.02.006 · Cited by 200
Inflammation Anergy in Human Intestinal Macrophages Is Due to Smad-induced IκBα Expression and NF-κB Inactivation
Smythies, L. E., Shen, R., Bimczok, D., Novak, L., Clements, R. H., Eckhoff, D. E., Bouchard, P., George, M. D., Hu, W. K., Dandekar, S., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.069955 · Cited by 191
Lupeol and stigmasterol suppress tumor angiogenesis and inhibit cholangiocarcinoma growth in mice via downregulation of tumor necrosis factor-α
Kangsamaksin, T., Chaithongyot, S., Wootthichairangsan, C., Hanchaina, R., Tangshewinsirikul, C., & Svasti, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189628 · Cited by 193
Butein, a Tetrahydroxychalcone, Inhibits Nuclear Factor (NF)-κB and NF-κB-regulated Gene Expression through Direct Inhibition of IκBα Kinase β on Cysteine 179 Residue
Pandey, M. K., Sandur, S. K., Sung, B., Sethi, G., Kunnumakkara, A. B., & Aggarwal, B. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700890200 · Cited by 193
T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses
Zhu, Y., Ju, S., Chen, E., Dai, S., Li, C., Morel, P. A., Liu, L., Zhang, X., & Lu, B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000749 · Cited by 189
A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications
Sedighzadeh, S. S., Khoshbin, A. P., Razi, S., Keshavarz‐Fathi, M., & Rezaei, N. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-1241 · Cited by 190
ERK activation drives intestinal tumorigenesis in Apcmin/+ mice
Lee, S. H., Hu, L., González-Navajas, J. M., Seo, G. S., Shen, C., Brick, J., Herdman, S., Varki, N. M., Corr, M., Lee, J., et al. (2010) · Nature Medicine · doi:10.1038/nm.2143 · Cited by 188
Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-κB
Zhao, T., Yasunaga, J., Satou, Y., Nakao, M., Takahashi, M., Fujii, M., & Matsuoka, M. (2008) · Blood · doi:10.1182/blood-2008-06-161729 · Cited by 199
Overweight and obesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America
Aballay, L. R., Eynard, A. R., Díaz, M. D. P., Navarro, A., & Muñoz, S. E. (2013) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00533.x · Cited by 195
IL-17 Enhances Tumor Development in Carcinogen-Induced Skin Cancer
Wang, L., Yi, T., Zhang, W., Pardoll, D. M., & Yu, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0775 · Cited by 191
Anti-inflammatory activity of methyl palmitate and ethyl palmitate in different experimental rat models
Saeed, N. M., El‐Demerdash, E., Abdel-Rahman, H. M., Algandaby, M. M., Al-Abbasi, F. A., & Abdel‐Naim, A. B. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.07.020 · Cited by 186
Molecular pathways and targets in cancer-related inflammation
Mantovani, A., Garlanda, C., & Allavena, P. (2010) · Annals of Medicine · doi:10.3109/07853890903405753 · Cited by 182
Dietary Glucosinolates Sulforaphane, Phenethyl Isothiocyanate, Indole-3-Carbinol/3,3′-Diindolylmethane: Antioxidative Stress/Inflammation, Nrf2, Epigenetics/Epigenomics and In Vivo Cancer Chemopreventive Efficacy
Fuentes, F., Paredes‐Gonzalez, X., & Kong, A. T. (2015) · Current Pharmacology Reports · doi:10.1007/s40495-015-0017-y · Cited by 189
Oral Consumption of Pomegranate Fruit Extract Inhibits Growth and Progression of Primary Lung Tumors in Mice
Khan, N., Afaq, F., Kweon, M., Kim, K., & Mukhtar, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3941 · Cited by 189
NFκB: a promising target for natural products in cancer chemoprevention
Luqman, S., & Pezzuto, J. M. (2010) · Phytotherapy Research · doi:10.1002/ptr.3171 · Cited by 187
Targeting microRNAs as key modulators of tumor immune response
Paladini, L., Fabris, L., Bottai, G., Raschioni, C., Călin, G. A., & Santarpia, L. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0375-2 · Cited by 184
FOXM1 (Forkhead box M1) in Tumorigenesis
Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 190
Biofilm Producing Salmonella Typhi: Chronic Colonization and Development of Gallbladder Cancer
Domenico, E. G. D., Cavallo, I., Pontone, M., Toma, L., & Ensoli, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091887 · Cited by 192
SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24- Phenotype
Bhat‐Nakshatri, P., Appaiah, H. N., Ballas, C. B., Pick-Franke, P. A., Goulet, R. J., Badve, S., Srour, E. F., & Nakshatri, H. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-411 · Cited by 182
Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation
Afify, S. M., & Seno, M. (2019) · Cancers · doi:10.3390/cancers11030345 · Cited by 188
The nuclear factor-κB pathway controls the progression of prostate cancer to androgen-independent growth.
Jin, R. J., Lho, Y., Connelly, L., Wang, Y., Yu, X., Saint Jean, L., Case, T. C., Ellwood-Yen, K., Sawyers, C. L., Bhowmick, N. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0107 · Cited by 182
Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis
González-Ramos, R., Van Langendonckt, A., Defrère, S., Lousse, J.-C., Colette, S., Devoto, L., & Donnez, J. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.01.013 · Cited by 179
Advances in the understanding of MYC‐induced lymphomagenesis
Klapproth, K., & Wirth, T. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08159.x · Cited by 180
Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis.
Algül, H., Treiber, M., Lesina, M., Nakhai, H., Saur, D., Geisler, F., Pfeifer, A., Paxian, S. A., & Schmid, R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29882 · Cited by 194
TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα
Ji, J., Ding, K., Luo, T., Zhang, X., Chen, A., Zhang, D., Li, G., Thorsen, F. A., Huang, B., Li, X., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00606-w · Cited by 181
Role of aryl hydrocarbon receptor in cancer
Feng, S., Cao, Z., & Wang, X. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.05.001 · Cited by 179
Chemokines: novel targets for breast cancer metastasis
Ali, S., & Lazennec, G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9073-z · Cited by 182
Crosstalk via the NF-κB signaling system
Basak, S., & Hoffmann, A. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.04.005 · Cited by 177
Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention
Neergheen, V. S., Bahorun, T., Taylor, E. W., Jen, L., & Aruoma, O. I. (2009) · Toxicology · doi:10.1016/j.tox.2009.10.010 · Cited by 180
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition
Sapienza, M. R., Fuligni, F., Agostinelli, C., Tripodo, C., Righi, S., Laginestra, M. A., Pileri, A., Mancini, M., Rossi, M., Ricci, F., et al. (2014) · Leukemia · doi:10.1038/leu.2014.64 · Cited by 179
Anti‐inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis‐associated colon cancer
Koh, S., Kim, J. M., Kim, I., Ko, S. H., & Kim, J. S. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12435 · Cited by 179
The PPARα-Dependent Rodent Liver Tumor Response Is Not Relevant to Humans: Addressing Misconceptions
Corton, J. C., Peters, J. M., & Klaunig, J. E. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2094-7 · Cited by 175
The Role of Nuclear Factor κB in the Interferon Response
Pfeffer, L. M. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0028 · Cited by 185
The complex interplay between autophagy and NF-κB signaling pathways in cancer cells.
Trocoli, A., & Djavaheri‐Mergny, M. (2011) · PubMed · Cited by 184
Toll-like receptors in pathophysiology of liver diseases
KIZILTAŞ, Ş. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i32.1354 · Cited by 180
The Role of NF‐κB in Hypoxia‐Induced Gene Expression
Taylor, C. T., & Cummins, E. P. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05024.x · Cited by 175
Targeting Protein Serine/Threonine Phosphatases for Drug Development
McConnell, J. L., & Wadzinski, B. E. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053140 · Cited by 175
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies
Gelfo, V., Romaniello, D., Mazzeschi, M., Sgarzi, M., Grilli, G., Morselli, A., Manzan, B., Rihawi, K., & Lauriola, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176009 · Cited by 182
The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link
Bowers, L. W., Rossi, E. L., Oâ€TMFlanagan, C. H., deGraffenried, L. A., & Hursting, S. D. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00077 · Cited by 186
Inducers of Heme Oxygenase-1
Ferrándiz, M. L., & Devesa, I. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783597399 · Cited by 175
MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signalling
Ahmad, R., Raina, D. B., Trivedi, V., Ren, J., Rajabi, H. N., Kharbanda, S. M., & Kufe, D. W. (2007) · Nature Cell Biology · doi:10.1038/ncb1661 · Cited by 174
Sleep disturbance, inflammation and depression risk in cancer survivors
Irwin, M. R., Olmstead, R. E., Ganz, P. A., & Haque, R. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.002 · Cited by 173
Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis
Ge, Z., Rogers, A. B., Feng, Y., Lee, A., Xu, S., Taylor, N. S., & Fox, J. G. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00939.x · Cited by 174
Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway
Ikebe, M., Kitaura, Y., Nakamura, M., Tanaka, H., Yamasaki, A., Nagai, S., 和田, 純., Yanai, K., Koga, K., Sato, N., et al. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21392 · Cited by 177
Inflammation and cancer
Eiró, N. (2012) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v4.i3.62 · Cited by 181
Modeling Colon Adenocarcinomas in Vitro
Dolznig, H., Rupp, C., Puri, C., Haslinger, C., Schweifer, N., Wieser, E., Kerjaschki, D., & Garin‐Chesa, P. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.015 · Cited by 177
Minireview: Inflammation: An Instigator of More Aggressive Estrogen Receptor (ER) Positive Breast Cancers
Baumgarten, S. C., & Frasor, J. M. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1302 · Cited by 173
The Role of Interleukin 17 in Tumour Proliferation, Angiogenesis, and Metastasis
Yang, B., Kang, H., Fung, A., Zhao, H., Wang, T., & Ma, D. (2014) · Mediators of Inflammation · doi:10.1155/2014/623759 · Cited by 175
B7-H3 role in the immune landscape of cancer.
Castellanos, J. R., Purvis, I. J., Labak, C. M., Guda, M. R., Tsung, A. J., Velpula, K. K., & Asuthkar, S. (2017) · Europe PMC (PubMed Central) · Cited by 172
Receptor-interacting protein kinase 3 is a predictor of survival and plays a tumor suppressive role in colorectal cancer
Feng, X., SONG, Q., Yu, A., Tang, H. Y., Peng, Z., & WANG, X. (2015) · Neoplasma · doi:10.4149/neo_2015_071 · Cited by 170
Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation
Wang, J. Q., Jeelall, Y. S., Ferguson, L. L., & Horikawa, K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00367 · Cited by 179
Revisiting the association between candidal infection and carcinoma, particularly oral squamous cell carcinoma
Bakri, M. M., Hussaini, H. M., Holmes, A. R., Cannon, R. D., & Rich, A. M. (2010) · Journal of Oral Microbiology · doi:10.3402/jom.v2i0.5780 · Cited by 172
Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-κB and AP-1 mediated transcription activation and as potential anti-inflammatory agents
Giri, R. S., Thaker, H. M., Giordano, T., Williams, J. M., Rogers, D., Sudersanam, V., & Vasu, K. K. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.10.031 · Cited by 168
Mitochondrial Function and Nuclear Factor-κB–Mediated Signaling in Radiation-Induced Bystander Effects
Zhou, H., Ivanov, V. N., Lien, Y., Davidson, M. M., & Hei, T. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5278 · Cited by 167
Rho Signaling and Tight Junction Functions
Terry, S. J., Nie, M., Matter, K., & Balda, M. S. (2010) · Physiology · doi:10.1152/physiol.00034.2009 · Cited by 177
The immune landscape and response to immune checkpoint blockade therapy in lymphoma
Kline, J. P., Godfrey, J. K., & Ansell, S. M. (2019) · Blood · doi:10.1182/blood.2019000847 · Cited by 166
Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue
Hursting, S. D., & Dunlap, S. M. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06737.x · Cited by 171
Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection.
Wu, S., & Sun, J. (2011) · PubMed · Cited by 165
Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKβ
Heyninck, K., Lahtela-Kakkonen, M. K., der Veken, P. V., Haegeman, G., & Berghe, W. V. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.004 · Cited by 164
TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization
Garlanda, C., Anders, H., & Mantovani, A. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.06.001 · Cited by 169
Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis
Zhao, S., Wu, D., Wu, P., Wang, Z., & Huang, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139598 · Cited by 168
TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis
Inokuchi‐Shimizu, S., Park, E. J., Roh, Y. S., Yang, L., Zhang, B., Song, J., Liang, S., Pimienta, M., Taniguchi, K., Wu, X., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74068 · Cited by 166
Self-citation
MiR-27b targets PPARγ to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells
Lee, J.-J., Drakaki, A., Iliopoulos, D., & Struhl, K. (2011) · Oncogene · doi:10.1038/onc.2011.543 · Cited by 167
Sirtuin-6–Dependent Genetic And Epigenetic Alterations Are Associated With Poor Clinical Outcome in Hepatocellular Carcinoma Patients
Marquardt, J. U., Fischer, K., Baus, K., Kashyap, A., Ma, S., Krupp, M., Linke, M., Teufel, A., Zechner, U., Strand, D. J., et al. (2013) · Hepatology · doi:10.1002/hep.26413 · Cited by 161
A Review of the Application of Inflammatory Biomarkers in Epidemiologic Cancer Research
Brenner, D. R., Scherer, D., Muir, K. R., Schildkraut, J. M., Boffetta, P., Spitz, M. R., Marchand, L. L., Chan, A. T., Goode, E. L., Ulrich, C. M., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0064 · Cited by 171
MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis
Li, S., Liang, X., Ma, L., Shen, L., Li, T., Zheng, L., Sun, A., Shang, W., Chen, C., Zhao, W., et al. (2017) · Oncogene · doi:10.1038/onc.2017.381 · Cited by 161
TNFα acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-κB-dependent pathways
Rivas, M. A., Carnevale, R. P., Proietti, C. J., Rosemblit, C., Béguelin, W., Salatino, M., Charreau, E. H., Frahm, I., Sapia, S., Brouckaert, P., et al. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.10.005 · Cited by 161
IP3 receptors in cell survival and apoptosis: Ca2+ release and beyond
Joseph, S. K., & Hajnóczky, G. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0719-7 · Cited by 162
Akt-dependent Activation of mTORC1 Complex Involves Phosphorylation of mTOR (Mammalian Target of Rapamycin) by IκB Kinase α (IKKα)
Dan, H. C., Ebbs, A., Pasparakis, M., Dyke, T. V., Bassères, D. S. D. S., & Baldwin, A. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554881 · Cited by 172
Colorectal cancer occurrence and treatment based on changes in intestinal flora
Si, H., Yang, Q. F., Hu, H., Ding, C., Wang, H., & Lin, X. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.004 · Cited by 167
miRNA regulation of cytokine genes
Asirvatham, A. J., Magner, W. J., & Tomasi, T. B. (2009) · Cytokine · doi:10.1016/j.cyto.2008.11.010 · Cited by 168
Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans
Irwin, M. R., Witarama, T., Caudill, M. M., Olmstead, R., & Breen, E. C. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.09.017 · Cited by 168
Circadian gene variants in cancer
Kettner, N. M., Katchy, C. A., & Fu, L. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.914808 · Cited by 147
Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients
Rapin, N., Bagger, F. O., Jendholm, J., Mora-Jensen, H. I., Krogh, A., Kohlmann, A., Thiede, C., Borregaard, N., Bullinger, L., Winther, O., et al. (2013) · Blood · doi:10.1182/blood-2013-02-485771 · Cited by 155
Inflammation and cancer: Breast cancer as a prototype
Mantovani, A., Marchesi, F., Porta, C., Sica, A., & Allavena, P. (2007) · The Breast · doi:10.1016/j.breast.2007.07.013 · Cited by 163
Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis
Shankar, S., Ganapathy, S., Chen, Q., & Srivastava, R. K. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-16 · Cited by 157
Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
DeNardo, D. G., & Coussens, L. M. (2007) · Cited by 156
NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors
Shin, V. Y., Jin, H., Ng, E. K., Cheng, A. S. L., Chong, W., Wong, C. Y., Leung, W. K., Sung, J. J. �., & Chu, K. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq240 · Cited by 158
Mechanisms of liver disease: cross-talk between the NF-κB and JNK pathways
Papa, S., Bubici, C., Zazzeroni, F., & Franzoso, G. (2009) · bchm · doi:10.1515/bc.2009.111 · Cited by 156
Gene Disruption Study Reveals a Nonredundant Role for TRIM21/Ro52 in NF-κB-Dependent Cytokine Expression in Fibroblasts
Yoshimi, R., Chang, T.-H., Wang, H., Atsumi, T., Morse, H. C., & Ozato, K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804121 · Cited by 156
Crystal Structure of a Human IκB Kinase β Asymmetric Dimer
Liu, S., Misquitta, Y., Olland, A. M., Johnson, M. A., Kelleher, K. S., Kriz, R., Lin, L., Stahl, M., & Mosyak, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.482596 · Cited by 154
Garcinol Regulates EMT and Wnt Signaling PathwaysIn VitroandIn Vivo, Leading to Anticancer Activity against Breast Cancer Cells
Ahmad, A., Sarkar, S. H., Bitar, B., Ali, S. S., Aboukameel, A., Sethi, S. N., Li, Y., Bao, B., Kong, D., Banerjee, S., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0232-t · Cited by 155
Chronic inflammation imposes aberrant cell fate in regenerating epithelia through mechanotransduction
Nowell, C. S., Odermatt, P. D., Azzolin, L., Hoehnel, S., Wagner, E. F., Fantner, G. E., Lütolf, M. P., Barrandon, Y., Piccolo, S., & Radtke, F. (2015) · Nature Cell Biology · doi:10.1038/ncb3290 · Cited by 155
Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic
Shah, F., Logsdon, D. P., Messmann, R. A., Fehrenbacher, J. C., Fishel, M. L., & Kelley, M. R. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0023-0 · Cited by 155
Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review
Wang, S., Huang, S., & Sun, Y. (2017) · BioMed Research International · doi:10.1155/2017/2646148 · Cited by 152
Inflammatory cardiac valvulitis in TAX1BP1‐deficient mice through selective NF‐κB activation
Iha, H., Péloponèse, J., Verstrepen, L., Zapart, G., Ikeda, F., Smith, C. D., Starost, M. F., Yedavalli, V. R. K., Heyninck, K., Đikić, I., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.5 · Cited by 156
Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis
González-Ramos, R., Donnez, J., Defrère, S., Leclercq, I. A., Squifflet, J. P., Lousse, J., & Langendonckt, A. V. (2007) · Molecular Human Reproduction · doi:10.1093/molehr/gam033 · Cited by 152
Reduced microRNA‐218 expression is associated with high nuclear factor kappa B activation in gastric cancer
Gao, C., Zhang, Z., Liu, W., Xiao, S., Gu, W.-Q., & Lü, H. (2009) · Cancer · doi:10.1002/cncr.24743 · Cited by 152
Endothelial cells: From innocent bystanders to active participants in immune responses
Al-Soudi, A., Kaaij, M. H., & Tas, S. W. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.008 · Cited by 162
Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation
Shaked, H., Hofseth, L. J., Chumanevich, A. P., Chumanevich, A. A., Wang, J., Wang, Y., Taniguchi, K., Gumá, M., Shenouda, S., Clevers, H. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211509109 · Cited by 159
Self-citation
Plumbagin‐induced apoptosis of human breast cancer cells is mediated by inactivation of NF‐κB and Bcl‐2
Ahmad, A., Banerjee, S., Wang, Z. P., Kong, D., & Sarkar, F. H. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21966 · Cited by 151
MicroRNA Involvement in Signaling Pathways During Viral Infection
Barbu, M. G., Condrat, C. E., Thompson, D. C., Bugnar, O. L., Crețoiu, D., Toader, O. D., Suciu, N., & Voinea, S. C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00143 · Cited by 151
Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies
Wang, C., Dai, S., Zhao, X., Zhang, Y., Gong, L., Fu, K., Ma, C., Peng, C. Y., & Li, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114882 · Cited by 152
Maslinic Acid, a Natural Phytoalexin-Type Triterpene from Olives — A Promising Nutraceutical?
Lozano-Mena, G., Sánchez-González, M., Juan, M., & Planas, J. (2014) · Molecules · doi:10.3390/molecules190811538 · Cited by 151
The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer
Luo, C., & Zhang, H. (2017) · Mediators of Inflammation · doi:10.1155/2017/5126048 · Cited by 159

Authors: Karin, M.
Affiliations: University of California San Diego (US)
Corresponding author: Karin, Michael
ORCID: Karin, Michael
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2006-05
Volume: 441
Issue: 7092
Pages: 431-436
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature04870
OpenAlex: W2315613727
Cited by: 3,519
References: 71
Citations by year: 2026: 60 · 2025: 97 · 2024: 111 · 2023: 118 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 133 · 2018: 168 · 2017: 149 · 2016: 192 · 2015: 235 · 2014: 203 · 2013: 231 · 2012: 250
FWCI: 15.68
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
Keywords: NF-κB, carcinogenesis, tumor progression, inflammation and cancer, apoptosis resistance, tumor surveillance, tumor angiogenesis, tumour invasiveness, chemoprevention, chemotherapeutic target, NF-κB signaling
MeSH terms: Animals, Humans, Inflammation, Liver Neoplasms, Neoplasms, Skin Neoplasms, NF-kappa B, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nuclear factor-κB in cancer development and progression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks